# Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host

**Authors:** José Afonso Guerra-Assunção, Ruairi McErlean, Katie Townsend, Selin Cankat, Leonhard M. Flaxl, Shengwei Jamie Tian, Thomas R. Turner, Neema P. Mayor, Judith Breuer, Leo Swadling, David M. Lowe

PMC · DOI: 10.1016/j.isci.2026.114917 · iScience · 2026-02-05

## TL;DR

A study shows how SARS-CoV-2 evolved for 2.5 years in an immunocompromised person, leading to immune escape.

## Contribution

The paper reveals extensive viral evolution and T cell immune evasion in a long-term SARS-CoV-2 infection.

## Key findings

- SARS-CoV-2 evolved with 56 non-synonymous mutations across 20 proteins during 2.5 years of infection.
- T cell epitopes were affected by mutations, leading to immune escape in 50-86% of tested epitopes.
- High T cell memory was observed despite undetectable antibodies and inhibitory receptor expression.

## Abstract

Prolonged virus-host interaction and suboptimal immunity during persistent SARS-CoV-2 infection of immunocompromised patients enables viral adaptation. We investigated viral evolution and immune escape during a 2.5-year persistent infection in a patient with multiple myeloma and rheumatoid arthritis receiving anti-CD20 therapy. Virus isolated 899-days post-infection revealed an ancestral B.31 lineage with extensive evolution (56 non-synonymous mutations across 20 viral proteins). Many mutations were private or convergent with those seen in other persistent infections and later variants. SARS-CoV-2-specific antibodies were undetectable. Despite prolonged antigen exposure, T cell memory was functional high-in-magnitude and breadth, but with inhibitory receptor expression and dominant spike-specific CD8 response. 38/56 mutations occurred in T cell epitopes, reducing MHC binding or immunogenicity for 69% of CD8 epitopes affected. Importantly, functional assays confirmed T cell escape at 50% (1/2) and 86% (6/7) of CD8 and CD4 epitopes tested in vitro. These findings reveal extensive viral adaptation and T cell immune evasion during persistent infection.

•SARS-CoV-2 persisted for 2.5 years in an immunocompromised host, evolving extensively•Sequencing revealed ancestral B.31 lineage with 56 NS convergent and unique changes•High magnitude functional T cell memory induced, with high inhibitory R expression•Mutations negatively impacted CD4 and CD8 epitopes, leading to immune escape

SARS-CoV-2 persisted for 2.5 years in an immunocompromised host, evolving extensively

Sequencing revealed ancestral B.31 lineage with 56 NS convergent and unique changes

High magnitude functional T cell memory induced, with high inhibitory R expression

Mutations negatively impacted CD4 and CD8 epitopes, leading to immune escape

Immunology; Immunity; Virology; Sequence analysis

## Linked entities

- **Diseases:** multiple myeloma (MONDO:0009693), rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Genes:** LAG3 (lymphocyte activating 3) [NCBI Gene 3902] {aka CD223}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, GZMH (granzyme H) [NCBI Gene 2999] {aka CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2}, SPECC1 (sperm antigen with calponin homology and coiled-coil domains 1) [NCBI Gene 92521] {aka CYTSB, HCMOGT-1, HCMOGT1, NSP, NSP5}, TNFRSF4 (TNF receptor superfamily member 4) [NCBI Gene 7293] {aka ACT35, CD134, IMD16, OX40, TXGP1L}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, N (nucleocapsid phosphoprotein) [NCBI Gene 43740575], VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}, ORF1ab (ORF1a polyprotein;ORF1ab polyprotein) [NCBI Gene 43740578], CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, E (envelope protein) [NCBI Gene 43740570], CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, TOX (thymocyte selection associated high mobility group box) [NCBI Gene 9760] {aka TOX1}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, TNFRSF9 (TNF receptor superfamily member 9) [NCBI Gene 3604] {aka 4-1BB, CD137, CDw137, ILA, IMD109}, M (membrane glycoprotein) [NCBI Gene 43740571], IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}
- **Diseases:** lung damage (MESH:D008171), COVID-19 (MESH:D000086382), Infection (MESH:D007239), multiple myeloma (MESH:D009101), breathlessness (MESH:D004417), hepatitis B and C. (MESH:D006509), cough (MESH:D003371), EBV (MESH:D020031), rheumatoid arthritis (MESH:D001172), inflammation (MESH:D007249), persistent infection (MESH:D000088562), viral (MESH:D014777), Coronavirus (MESH:D018352), death (MESH:D003643), antibody-deficient (MESH:D007153), Influenza (MESH:D007251), immunodeficiency disorders (MESH:D000081207), fever (MESH:D005334), hematologic malignancies (MESH:D019337), fungal (MESH:D009181), hypoxia (MESH:D000860), sepsis (MESH:D018805), Long-COVID (MESH:D000094024), CMV (MESH:D003586), wheezing (MESH:D012135), AIDS (MESH:D000163), bacterial infection (MESH:D001424), respiratory deterioration (MESH:D012131), pneumonia (MESH:D011014), tuberculosis (MESH:D014376), secondary immunodeficiency (MESH:D000068376), seroconversion (MESH:D006679), airways disease (MESH:D029424), NS (MESH:D056770)
- **Chemicals:** rituximab (MESH:D000069283), nitrogen (MESH:D009584), remdesivir (MESH:C000606551), streptomycin (MESH:D013307), prednisolone (MESH:D011239), brefeldin A (MESH:D020126), BV605 (-), penicillin (MESH:D010406), PBS (MESH:D007854), biotin (MESH:D001710), DMSO (MESH:D004121), CO2 (MESH:D002245), H2O (MESH:D014867)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Homo sapiens (human, species) [taxon 9606], Parechovirus (genus) [taxon 138954], Hungerfordia sp. U (species) [taxon 563713], Enterovirus (genus) [taxon 12059], Haemophilus influenzae (species) [taxon 727], Respiratory syncytial virus (no rank) [taxon 12814], Sus scrofa (pig, species) [taxon 9823], Human immunodeficiency virus 1 (no rank) [taxon 11676], human metapneumovirus (no rank) [taxon 162145], Coronaviridae (family) [taxon 11118], Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Mutations:** Y00146X, V149A, D1168A, T573I, I121L, D364N, K977Q, P104S, T30I, L3606F, A1078V, D22G, E180D, D614G, D54Y, A411V, S84L, F157L, S327L
- **Cell lines:** hu-1 — Homo sapiens (Human), Finite cell line (CVCL_B0BH)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936837/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936837/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936837/full.md

---
Source: https://tomesphere.com/paper/PMC12936837